Article
Prostate cancer: germline prediction for a commonly variable malignancy.
BJU international - 1 Dec 2012
Bambury Richard M, Gallagher David J
Abstract excerpt
UNLABELLED: What's known on the subject? and What does the study add? Prostate cancer is a heterogeneous disease and biomarkers to predict its incidence and subsequent clinical behaviour are needed to tailor screening, prevention and therapeutic strategies. Rare mutations in genes such as BRCA1, BRCA2 and HOXB13 can affect prostate cancer incidence and/or clinical behaviour. Genome wide association studies (GWAS)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
